Related Experiment Video
Updated: Aug 24, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Functional expression of TWEAK in human hepatocellular carcinoma: possible implication in cell proliferation and
Tomoyuki Kawakita1, Katsuya Shiraki, Yutaka Yamanaka
1First Department of Internal Medicine, Mie University School of Medicine, Tsu, Mie 514-8507, Japan.
Abstract:
TNF-like weak inducer of apoptosis (TWEAK) is a member of the TNF family whose transcripts are expressed in various human tissues. Since TWEAK has a variety of biological activities, we investigated TWEAK sensitivity, expression, and physiological role in human hepatocellular carcinomas (HCCs). Tweak receptor was detected in four kinds of HCC cells. TWEAK significantly promoted cell proliferation and induced nuclear factor-kappaB activation in all HCC cells. Surprisingly, we found that HCC cells constitutively express TWEAK. In addition, soluble TWEAK was detected in culture medium. We found that TWEAK also promotes cell proliferation and induces the secretion of IL-8 and MCP-1 in human umbilical vein endothelial cell. Finally, culture medium from Sh-Hep1 cells incubated with anti-TWEAK antibody significantly inhibited endothelial cell tube formation. In conclusion, these results indicate that TWEAK might play a critical role in HCC cellular proliferation using both autocrine and paracrine mechanisms, and modulate tumor-related angiogenesis.
Insights
TNF-like weak inducer of apoptosis (TWEAK) promotes hepatocellular carcinoma (HCC) cell proliferation via autocrine and paracrine signaling. TWEAK also influences tumor angiogenesis by affecting endothelial cells.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- TNF-like weak inducer of apoptosis (TWEAK) is a TNF family member with diverse biological activities.
- TWEAK expression is observed in various human tissues.
- The role of TWEAK in human hepatocellular carcinomas (HCCs) requires further investigation.
Purpose of the Study:
- To investigate TWEAK sensitivity, expression, and its physiological role in human HCCs.
- To determine TWEAK's impact on HCC cell proliferation and signaling pathways.
- To assess TWEAK's influence on tumor-related angiogenesis.
Main Methods:
- Detection of TWEAK receptor in HCC cell lines.
- Assessment of TWEAK's effect on HCC cell proliferation and NF-κB activation.
- Evaluation of TWEAK's role in human umbilical vein endothelial cell (HUVEC) proliferation, IL-8, and MCP-1 secretion.
- Inhibition of HUVEC tube formation using anti-TWEAK antibody.
Main Results:
- TWEAK receptor was detected in four HCC cell lines.
- TWEAK significantly promoted HCC cell proliferation and induced NF-κB activation.
- HCC cells constitutively express TWEAK, with soluble TWEAK detected in culture medium.
- TWEAK promoted HUVEC proliferation and induced IL-8 and MCP-1 secretion.
- Anti-TWEAK antibody inhibited endothelial cell tube formation.
Conclusions:
- TWEAK plays a critical role in HCC cellular proliferation through autocrine and paracrine mechanisms.
- TWEAK modulates tumor-related angiogenesis by affecting endothelial cells.
- Targeting TWEAK may offer a therapeutic strategy for HCC.
More Related Videos
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
09:52A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
Published on: September 20, 2016
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...